Document is current
Any future updates will be listed below
-
Authors
Lee, Jimin
Stewart, Cameron https://orcid.org/0000-0002-2786-6256
Schäfer, Alexandra https://orcid.org/0000-0002-4760-4923
Leaf, Elizabeth M.
Park, Young-Jun https://orcid.org/0000-0003-2901-6949
Asarnow, Daniel
Powers, John M. https://orcid.org/0000-0002-0485-9109
Treichel, Catherine
Sprouse, Kaitlin R.
Corti, Davide https://orcid.org/0000-0002-5797-1364
Baric, Ralph https://orcid.org/0000-0001-6827-8701
King, Neil P. https://orcid.org/0000-0002-2978-4692
Veesler, David https://orcid.org/0000-0002-6019-8675
-
Funding
Funding for this research was provided by:
Howard Hughes Medical Institute
- License Information
-
More Information
Article History
Received: 4 January 2024
Accepted: 13 June 2024
First Online: 28 June 2024
Competing interests
: N.P.K. and D.V. are named as inventors on patents for coronavirus nanoparticle vaccines filed by the University of Washington. N.P.K. is a paid consultant of Icosavax, Inc. and has received unrelated sponsored research agreements from Pfizer and GSK. D.C. is an employee of Vir Biotechnology and may hold shares in Vir Biotechnology. R.S.B. is a member of advisory boards for VaxArt, Takeda and Invivyd, and has collaborative projects with Gilead, J&J, and Hillevax, focused on unrelated projects.
